A citation-based method for searching scientific literature

Daniel R Scoles, Pratap Meera, Matthew D Schneider, Sharan Paul, Warunee Dansithong, Karla P Figueroa, Gene Hung, Frank Rigo, C Frank Bennett, Thomas S Otis, Stefan M Pulst. Nature 2017
Times Cited: 140



Lindsay A Becker, Brenda Huang, Gregor Bieri, Rosanna Ma, David A Knowles, Paymaan Jafar-Nejad, James Messing, Hong Joo Kim, Armand Soriano, Georg Auburger, Stefan M Pulst, J Paul Taylor, Frank Rigo, Aaron D Gitler. Nature 2017
Times Cited: 222




List of shared articles



Times cited

Role and therapeutic potential of liquid-liquid phase separation in amyotrophic lateral sclerosis.
Donya Pakravan, Gabriele Orlando, Valérie Bercier, Ludo Van Den Bosch. J Mol Cell Biol 2021
2

Antisense Drugs Make Sense for Neurological Diseases.
C Frank Bennett, Holly B Kordasiewicz, Don W Cleveland. Annu Rev Pharmacol Toxicol 2021
3

Body Mass Index Is Significantly Associated With Disease Severity in Spinocerebellar Ataxia Type 2 Patients.
Luis E Almaguer-Mederos, Ilbedis Pérez-Ávila, Raúl Aguilera-Rodríguez, Maria Velázquez-Garcés, Dennis Almaguer-Gotay, Ricardo Hechavarría-Pupo, Annelié Rodríguez-Estupiñán, Georg Auburger. Mov Disord 2021
1

Atxn2-CAG100-KnockIn mouse spinal cord shows progressive TDP43 pathology associated with cholesterol biosynthesis suppression.
Júlia Canet-Pons, Nesli-Ece Sen, Aleksandar Arsović, Luis-Enrique Almaguer-Mederos, Melanie V Halbach, Jana Key, Claudia Döring, Anja Kerksiek, Gina Picchiarelli, Raphaelle Cassel,[...]. Neurobiol Dis 2021
2

Antagonistic roles for Ataxin-2 structured and disordered domains in RNP condensation.
Amanjot Singh, Joern Hulsmeier, Arvind Reddy Kandi, Sai Shruti Pothapragada, Jens Hillebrand, Arnas Petrauskas, Khushboo Agrawal, Krishnan Rt, Devasena Thiagarajan, Deepa Jayaprakashappa,[...]. Elife 2021
1

Staufen1 in Human Neurodegeneration.
Sharan Paul, Warunee Dansithong, Karla P Figueroa, Mandi Gandelman, Daniel R Scoles, Stefan M Pulst. Ann Neurol 2021
1

Gene therapy for ALS: A review.
Defne A Amado, Beverly L Davidson. Mol Ther 2021
1

Spinocerebellar ataxia clinical trials: opportunities and challenges.
Sarah M Brooker, Chandrakanth Reddy Edamakanti, Sara M Akasha, Sheng-Han Kuo, Puneet Opal. Ann Clin Transl Neurol 2021
0

DNAzyme Cleavage of CAG Repeat RNA in Polyglutamine Diseases.
Nan Zhang, Brittani Bewick, Jason Schultz, Anjana Tiwari, Robert Krencik, Aijun Zhang, Kaho Adachi, Guangbin Xia, Kyuson Yun, Partha Sarkar,[...]. Neurotherapeutics 2021
0

Antisense oligonucleotide therapeutics in neurodegenerative diseases: the case of polyglutamine disorders.
Ana C Silva, Diana D Lobo, Inês M Martins, Sara M Lopes, Carina Henriques, Sónia P Duarte, Jean-Cosme Dodart, Rui Jorge Nobre, Luis Pereira de Almeida. Brain 2020
14

Fetal antisense oligonucleotide therapy for congenital deafness and vestibular dysfunction.
Lingyan Wang, J Beth Kempton, Han Jiang, Francine M Jodelka, Alev M Brigande, Rachel A Dumont, Frank Rigo, Jennifer J Lentz, Michelle L Hastings, John V Brigande. Nucleic Acids Res 2020
7

ALS-associated genes in SCA2 mouse spinal cord transcriptomes.
Daniel R Scoles, Warunee Dansithong, Lance T Pflieger, Sharan Paul, Mandi Gandelman, Karla P Figueroa, Frank Rigo, C Frank Bennett, Stefan M Pulst. Hum Mol Genet 2020
6

Divergence, Convergence, and Therapeutic Implications: A Cell Biology Perspective of C9ORF72-ALS/FTD.
Xiaoqiang Tang, Arturo Toro, Sahana T G, Junli Gao, Jessica Chalk, Björn Oskarsson, Ke Zhang. Mol Neurodegener 2020
8

Current Status of Antisense Oligonucleotide-Based Therapy in Neuromuscular Disorders.
Flavien Bizot, Adeline Vulin, Aurélie Goyenvalle. Drugs 2020
3

Mid-Gestation lethality of Atxn2l-Ablated Mice.
Jana Key, Patrick N Harter, Nesli-Ece Sen, Elise Gradhand, Georg Auburger, Suzana Gispert. Int J Mol Sci 2020
3

ALS Genetics: Gains, Losses, and Implications for Future Therapies.
Garam Kim, Olivia Gautier, Eduardo Tassoni-Tsuchida, X Rosa Ma, Aaron D Gitler. Neuron 2020
31

Mouse Ataxin-2 Expansion Downregulates CamKII and Other Calcium Signaling Factors, Impairing Granule-Purkinje Neuron Synaptic Strength.
Aleksandar Arsović, Melanie Vanessa Halbach, Júlia Canet-Pons, Dilhan Esen-Sehir, Claudia Döring, Florian Freudenberg, Nicoletta Czechowska, Kay Seidel, Stephan L Baader, Suzana Gispert,[...]. Int J Mol Sci 2020
2

Generation of Spinocerebellar Ataxia Type 2 induced pluripotent stem cell lines, CHOPi002-A and CHOPi003-A, from patients with abnormal CAG repeats in the coding region of the ATXN2 gene.
Jean Ann Maguire, Alyssa L Gagne, Pedro Gonzalez-Alegre, Beverly L Davidson, Vikram Shakkottai, Paul Gadue, Deborah L French. Stem Cell Res 2019
5

MSGP: the first database of the protein components of the mammalian stress granules.
Catarina Nunes, Isa Mestre, Adriana Marcelo, Rebekah Koppenol, Carlos A Matos, Clévio Nóbrega. Database (Oxford) 2019
19

Disruption of RNA Metabolism in Neurological Diseases and Emerging Therapeutic Interventions.
Julia K Nussbacher, Ricardos Tabet, Gene W Yeo, Clotilde Lagier-Tourenne. Neuron 2019
67

Antisense oligonucleotides: A primer.
Daniel R Scoles, Eric V Minikel, Stefan M Pulst. Neurol Genet 2019
45

2


Antisense Oligonucleotide Therapies for Neurodegenerative Diseases.
C Frank Bennett, Adrian R Krainer, Don W Cleveland. Annu Rev Neurosci 2019
54

Generation of an Atxn2-CAG100 knock-in mouse reveals N-acetylaspartate production deficit due to early Nat8l dysregulation.
Nesli-Ece Sen, Júlia Canet-Pons, Melanie V Halbach, Aleksandar Arsovic, Ulrich Pilatus, Woon-Hyung Chae, Zeynep-Ece Kaya, Kay Seidel, Ewa Rollmann, Michel Mittelbronn,[...]. Neurobiol Dis 2019
13

Calcium-responsive transactivator (CREST) toxicity is rescued by loss of PBP1/ATXN2 function in a novel yeast proteinopathy model and in transgenic flies.
Sangeun Park, Sei-Kyoung Park, Naruaki Watanabe, Tadafumi Hashimoto, Takeshi Iwatsubo, Tatyana A Shelkovnikova, Susan W Liebman. PLoS Genet 2019
2

Molecular Mechanisms and Therapeutics for Spinocerebellar Ataxia Type 2.
Polina A Egorova, Ilya B Bezprozvanny. Neurotherapeutics 2019
11

In Human and Mouse Spino-Cerebellar Tissue, Ataxin-2 Expansion Affects Ceramide-Sphingomyelin Metabolism.
Nesli-Ece Sen, Aleksandar Arsovic, David Meierhofer, Susanne Brodesser, Carola Oberschmidt, Júlia Canet-Pons, Zeynep-Ece Kaya, Melanie-Vanessa Halbach, Suzana Gispert, Konrad Sandhoff,[...]. Int J Mol Sci 2019
10

Recent Advances in the Treatment of Cerebellar Disorders.
Hiroshi Mitoma, Mario Manto, Jordi Gandini. Brain Sci 2019
2


Recent insights into the cellular and molecular determinants of aging.
Linhao Ruan, Xi Zhang, Rong Li. J Cell Sci 2018
12

Spinocerebellar Ataxia Type 2.
Daniel R Scoles, Stefan M Pulst. Adv Exp Med Biol 2018
12


Murine knockin model for progranulin-deficient frontotemporal dementia with nonsense-mediated mRNA decay.
Andrew D Nguyen, Thi A Nguyen, Jiasheng Zhang, Swathi Devireddy, Ping Zhou, Anna M Karydas, Xialian Xu, Bruce L Miller, Frank Rigo, Shawn M Ferguson,[...]. Proc Natl Acad Sci U S A 2018
22

Assisted delivery of antisense therapeutics in animal models of heritable neurodegenerative and neuromuscular disorders: a systematic review and meta-analysis.
M Leontien van der Bent, Omar Paulino da Silva Filho, Judith van Luijk, Roland Brock, Derick G Wansink. Sci Rep 2018
2